The In Vitro Fertilization and Reproductive Health Center of Koç University Hospital
 
  • Adopts proven and up-to-date diagnostic and treatment approaches; 
  • Closely follows scientific developments, goes beyond practice and also contributes to science with research;  
  • Has an experienced team that follows the principle of constant improvement; 
  • Is equipped with powerful and recent technological infrastructure; 
  • Achieves high success rates; 
  • Takes into consideration each individual’s intrinsic circumstances and needs; 
  • Prioritizes patient safety and health; and
  • Promotes ethical as well as humanitarian values on the path to successful outcomes. 

The center serves under the light of ethical values by adopting approaches of scientifically proven efficacy. Empowered by globally renowned and internationally experienced physicians, the center consistently contributes to care of all patients at the center and all around the world with around 200 scientific researches published on international peer-reviewed journals. Clinic, laboratory, patient care and patient relations teams operate in harmony so as to provide a safe and peaceful environment for couples presenting to the center. 

Our laboratory is equipped with cutting-edge technological equipment. More importantly, it is run by an experienced and competent team capable of performing all advanced procedures. 

Beyond being an in vitro fertilization center and as part of one of the top university hospitals in Turkey, we are able to request opinions and medical/technical support from every department, when necessary.
 

Service Subcategories of the In Vitro Fertilization and Reproductive Health Center

  • Assisted reproductive techniques:
    • In vitro fertilization (IVF)
    • Micro-injection (intracytoplasmic sperm injection, ICSI)
    • In utero insemination (IUI)
    • Surgical sperm extraction (TESA, TESE, micro-TESE)
    • Cryopreservation for women who have a low ovarian reserve (risk of early menopause) or wish to have their eggs frozen in order to sustain their chances of fertility in older ages
    • Sperm, egg, tissue or embryo cryopreservation for patients who face the risk of sustaining ovarian/testicular damage during treatment of cancer or other diseases
    • Genetic screening and diagnosis in embryo (pre-implantation genetic screening and diagnosis: PGS)
    • Fertility protection surgery and cryopreservation of ovarian tissue, eggs, sperm or embryos prior to cancer treatment or in cases where ovarian reserve is at risk
    • EmbryoScope/Time-lapse technology 
    • Sperm analysis
  • Diagnosis of congenital (septum uteri etc.) or acquired (adhesion, myoma, adenomyoma, polyp etc.) uterine conditions with 3D ultrasound 
  • Diagnosis and treatment of advanced endometriosis
  • Investigation of recurrent miscarriage
  • Clinical genetic consultancy

FREQUENTLY ASKED QUESTIONS

We issue reports for couples who are going to receive treatment at our clinic, meet the legal requirements and wish to benefit from SSI support. It is also possible for couples to submit reports issued at other centers for use during their treatment at our center.
On condition that the applicant meets the requirements, we issue the official report that is legally obligatory prior to treatment of female patients whose ovarian reserve has diminished or who wish to have their eggs frozen in order to sustain their chances of fertility in older ages.
The majority of individuals who visit our center experience difficulties with conception or would like to sustain their chances of reproduction in the future. Some of the relevant primary conditions can be listed as follows: 
  • Patients who are having difficulties with conception because of polycystic ovarian syndrome or ovulation problems
  • Infertility associated with sperm motility, azoospermia or low sperm count
  • Infertility associated with blocked or damaged fallopian tubes
  • Endometriosis and associated infertility
  • Congenital uterine deformities 
  • Conception difficulties due to underlying reasons like myoma, adenomyoma or polyp
  • Reduced ovarian capacity
  • Women who have concerns about reproduction in the feature owing to older age or diminished ovarian reserve
  • Patients who are at risk of compromising reproductive capacity because of treatment of cancer or other diseases 
  • Women who have experienced recurrent miscarriages
  • Couples who have a history of recurrent failed in vitro fertilization
  • Couples who would like to receive information regarding transfer of inherited diseases to children
The following staff members work at our center:
  • Gynecologists specialized in reproductive endocrinology and infertility
  • Urology specialists
  • Embryologists
  • IVF and reproductive health nurses